Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
Nikos Papadimitriou(University of Thessaly), Evelyn M. Monninkhof(Utrecht University), Neil Murphy(Centre international de recherche sur le cancer), Heather Hampel(City of Hope), Krasimira Aleksandrova(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Andrea Gsur(Comprehensive Cancer Center Vienna), Steven Gallinger(Ontario Institute for Cancer Research), Graham G. Giles(The University of Melbourne), Jenny Chang‐Claude(Universität Hamburg), Annika Lindblom(Karolinska University Hospital), Li Hsu(University of Washington), Demetrius Albanes(National Cancer Institute), Jane C. Figueiredo(University of Southern California), Noralane M. Lindor(Mayo Clinic in Arizona), Tilman Kühn(Queen's University Belfast), Sergi Castellvı́-Bel(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Tabitha A. Harrison(University of Washington), Michael Hoffmeister(German Cancer Research Center), Edward L. Giovannucci(Massachusetts Department of Public Health), Niki Dimou(Centre international de recherche sur le cancer), Christopher I. Li(Fred Hutch Cancer Center), Roger L. Milne(The University of Melbourne), Jeroen R. Huyghe(Fred Hutch Cancer Center), Sanford D. Markowitz(Howard Hughes Medical Institute), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Nabila Kazmi(University of Bristol), Tim Robinson(University of Bristol), Giovanna Masala(Piedmont Reference Center for Epidemiology and Cancer Prevention), Daniel D. Buchanan(The Royal Melbourne Hospital), Merete Ellingjord‐Dale(Imperial College London), Brigid M. Lynch(The University of Melbourne), Richard M. Martin(Drug Safety Research Unit), Sonja I. Berndt(Department of Health and Human Services), Andrew T. Chan(Harvard University), Stephen B. Gruber(City Of Hope National Medical Center), Anne M. May(Utrecht University), Temitope O. Keku(University of North Carolina at Chapel Hill), Carlo La Vecchia(University of Milan), Hermann Brenner(Universidad de Granada), Jochen Hampe(Else Kröner-Fresenius-Stiftung), José María Huerta(Instituto Murciano de Investigación Biosanitaria), Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Sophia Harlid(Umeå University), Mark A. Jenkins(The University of Melbourne), Peter T. Campbell(American Cancer Society), John L. Hopper(The University of Melbourne), D. Timothy Bishop(University of Leeds), Sarah J. Lewis(University of Bristol), Li Li(Mount Sinai Hospital), Barbara L. Banbury(Fred Hutch Cancer Center), Konstantinos K. Tsilidis(University of Ioannina)
Cited by 694
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k